These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4403558)

  • 21. [Anaplasmosis in Taiwan. II. Import of exotic cattle and premunition with Anaplasma centrale].
    Otte E; Kiltz HH
    Berl Munch Tierarztl Wochenschr; 1968 Nov; 81(21):428-33. PubMed ID: 5693575
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunization against babesiasis and anaplasmosis in 40 Charollais cattle imported to Kenya and report the incidence of photosensitization].
    Löhr KF
    Zentralbl Veterinarmed B; 1969 Feb; 16(1):40-6. PubMed ID: 5389131
    [No Abstract]   [Full Text] [Related]  

  • 23. Anaplasmosis: focusing on host-vector-pathogen interactions for vaccine development.
    de la Fuente J; Ayoubi P; Blouin EF; Almazán C; Naranjo V; Kocan KM
    Ann N Y Acad Sci; 2006 Oct; 1078():416-23. PubMed ID: 17114750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaplasmosis solutions on a herd by herd basis.
    Garlick NL
    Proc Annu Meet U S Anim Health Assoc; 1967; 71():63-70. PubMed ID: 5257340
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular epidemiology of human and bovine anaplasmosis in southern Europe.
    Naranjo V; Ruiz-Fons F; Höfle U; Fernández de Mera IG; Villanúa D; Almazán C; Torina A; Caracappa S; Kocan KM; Gortázar C; De La Fuente J
    Ann N Y Acad Sci; 2006 Oct; 1078():95-9. PubMed ID: 17114686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High serological prevalence of bovine anaplasmosis in North-Cameroon].
    Chollet JY
    Rev Elev Med Vet Pays Trop; 1995; 48(1):17-8. PubMed ID: 7569223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Notes on bovine babesiosis and anaplasmosis in Madagascar. VI. Artificial premunization].
    Uilenberg G
    Rev Elev Med Vet Pays Trop; 1971; 24(1):23-35. PubMed ID: 5106007
    [No Abstract]   [Full Text] [Related]  

  • 28. [Notes on bovine babesiosis and anaplasmosis in Madagascar. V. A. Immunity and premunition. B. Epizootology].
    Uilenberg G
    Rev Elev Med Vet Pays Trop; 1970; 23(4):439-54. PubMed ID: 5535538
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of mosquitoes in the transmission of the causative agent of anaplasmosis].
    Artemenko LP; Ponomarenko VIa
    Veterinariia; 1973 Jun; 49(6):64-6. PubMed ID: 4145963
    [No Abstract]   [Full Text] [Related]  

  • 30. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bovine anaplasmosis].
    Artemenko LP
    Veterinariia; 1974 Dec; (12):57-8. PubMed ID: 4450465
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anaplasmosis in a Swiss dairy farm: an epidemiological outbreak investigation].
    Brülisauer F; Thoma R; Cagienard A; Hofmann-Lehmann R; Lutz H; Meli ML; Regula G; Jörger K; Perl R; Dreher UM; Braun U; Stärk KD
    Schweiz Arch Tierheilkd; 2004 Oct; 146(10):451-9. PubMed ID: 15526601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprophylaxis of vector-borne anaplasmosis with sustained-release boluses.
    byford RL; Riner JL; Kocan KM; Stratton LG; Hair JA
    Am J Vet Res; 1981 Dec; 42(12):2088-9. PubMed ID: 7340579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A field survey of bovine anaplasmosis incidence in central Kenya.
    Thedford TR; Cook RH
    Trop Anim Health Prod; 1976 Nov; 8(4):202. PubMed ID: 996932
    [No Abstract]   [Full Text] [Related]  

  • 35. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
    Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of an immunosensor for the diagnosis of bovine anaplasmosis.
    Silva M; Wilkowsky S; De Echaide ST; Farber M; Oliva A
    Ann N Y Acad Sci; 2006 Oct; 1081():379-81. PubMed ID: 17135541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of terramycin/LA-200 administered during the prepatent period of anaplasmosis.
    Eckblad WP; Lincoln SD; Magonigle RA
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):44-52. PubMed ID: 298933
    [No Abstract]   [Full Text] [Related]  

  • 39. Bovine anaplasmosis in the coast range area of California.
    CHRISTENSEN JF; OSEBOLD JW; DOUGLAS JR
    J Am Vet Med Assoc; 1962 Oct; 141():952-7. PubMed ID: 14021096
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of three methods of immunization against bovine anaplasmosis: an examination of postvaccinal effects.
    Corrier DE; Vizcaino O; Carson CA; Ristic M; Kuttler KL; Treviño GS; Lee AJ
    Am J Vet Res; 1980 Jul; 41(7):1062-5. PubMed ID: 7436099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.